Sealife Pharma
Tulln, Niederosterreich, Austria
About Sealife Pharma
Sealife is a leading marine biopharma company pioneering the discovery and development of novel biochemistry isolated from the under-explored biological diversity of marine fungi. Their core focus is to develop novel antibiotics to treat multi-drug resistant Gram negative and Gram positive infections e.g. Pseudomonas aeruginosa, Acinetobacter baumanii, Penicillin resistant Streptococci pneumoniae (PRSP), MRSA and Vancomycin resistant enterococci (VRE). In addition, Sealife has discovery and development activities in the development of antimicrobials and disinfection agents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Mar 2011)
- Website: sealifepharma.com
- Phone: +43 664 2443774
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sealife-pharma-2594186 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.